TREATMENT OF RESISTANT WALDENSTROM'S MACROGLOBULINEMIA WITH HIGH DOSE GLUCOCORTICOSTEROIDS
- 1 February 1988
- journal article
- Published by Wiley in Australian and New Zealand Journal of Medicine
- Vol. 18 (1) , 77-78
- https://doi.org/10.1111/j.1445-5994.1988.tb02249.x
Abstract
We examined the efficacy of high dose glucocorticosteroids in two patients with Waldenstrom's macroglobulinemia resistant to other forms of therapy. Both patients demonstrated marked falls in total protein, paraprotein and viscosity levels, after only short periods on this regimen. There was no significant toxicity. We conclude that high dose dexamethasone may offer significant benefits in the treatment of Waldenstrom's macroglobulinemia.Keywords
This publication has 9 references indexed in Scilit:
- High-Dose Glucocorticoid Treatment of Resistant MyelomaAnnals of Internal Medicine, 1986
- Plasmapheresis in Hyperviscosity SyndromeActa Medica Scandinavica, 1985
- Combination chemotherapy (M-2) protocol (BCNU, cyclophosphamide, vincristine, melphalan, and prednisone) for Waldenstrom macroglobulinemia: preliminary reportBlood, 1982
- Successful doxorubicin therapy of primary macroglobulinemia resistant to alkylating agentsAmerican Journal of Hematology, 1980
- Experience with Large Volume Plasmapheresis in Malignant Paraproteinemia and Immune DisordersAustralian and New Zealand Journal of Medicine, 1978
- Clinical and pathologic features of Waldenström's macroglobulinemia in seven patients with serum monoclonal IgG or IgAThe American Journal of Medicine, 1977
- Waldenström's macroglobulinemiaThe American Journal of Medicine, 1966
- Serum protein disorders causing clinical symptoms in malignant neoplastic diseaseJournal of Chronic Diseases, 1963
- Plasmapheresis Therapy in MacroglobulinemiaAnnals of Internal Medicine, 1963